This study is designed to evaluate the efficacy of a single dose of 100 µg of MM-120 (D-lysergic acid diethylamide D-tartrate), versus placebo, for the treatment of depression symptoms.

This study is sponsored by Definium Therapeutics

For adults with a diagnosis of Major Depressive Disorder (MDD) currently experiencing a Major Depressive Episode (MDE).

The goal of this study is to evaluate the efficacy, safety, and tolerability of HLP003, compared to placebo, in treating symptoms of MDD in adult participants.

This study is sponsored by Helus.

For adults living with Post Traumatic Stress Disorder (PTSD)

The purpose of this study is to assess the efficacy, safety, and tolerability of TSND-201 for the treatment of PTSD symptoms compared to placebo

This study is sponsored by Transcend Therapeutics, Inc.